-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Business Meeting

Program: General Sessions
Tuesday, December 8, 2020: 11:15 AM-11:30 AM
Chair:
Stephanie J. Lee, MD, MPH, President, American Society of Hematology, Clinical Research Division, Fred Hutchinson Cancer Research Center
Disclosures:
Lee: AstraZeneca: Research Funding; Incyte: Consultancy, Research Funding; Amgen: Research Funding; Kadmon: Research Funding; Novartis: Research Funding; Pfizer: Consultancy, Research Funding; Syndax: Research Funding; Takeda: Research Funding.
At least one month prior to the annual meeting, reports on ASH's financial status, awards, and journals, Blood and Blood Advances, as well as information about the Society's leadership nominations, are made available online for review by ASH members. Under normal circumstances, these reports are approved by the Active and International members during the in-person Business Meeting; however, the Executive Committee has requested for a vote via email in advance. The 2020 Business Meeting will be amended accordingly. Dr. Stephanie Lee will acknowledge the incoming Vice President, Secretary, and Councilors, and afterwards she and Dr. Martin Tallman will conclude the session with the traditional passing of the gavel.
See more of: General Sessions